Canada has always invested in brain science, even during fiscal challenges. While others pursue AI dominance through speed and scale, we could lead by putting human cognition at the centre.
On Sunday, October 26th, Riverdale Farm in Toronto came alive with laughter, energy, and purpose as dozens gathered for the first-ever Functional Phil Community Walk. At the heart of this fundraiser was Philippe Marsan, better known to his clients and community as Functional Phil.
Fellowships advance sex and gender research in dementia
In early 2024, two outstanding trainees in brain health research—Dr. Natasha Clarke and Dr. Rikki Lissaman—each received a postdoctoral fellowship of $60,000 a year for two years through the Canadian Consortium on Neurodegeneration in Aging (CCNA) Phase II Women, Sex and Gender in Dementia (WSGD) cross-cutting program (now called the Sex and Gender Hub). They are two of the four trainees to receive the award that Brain Canada helped fund as a proud partner of the CCNA, a pan-Canadian collaborative effort making strides in our understanding and treatment of dementia.
Brain Canada Foundation announced that France Chrétien Desmarais, C.M., has been appointed Chair of its Board of Directors. She succeeds Naomi Azrieli, O.C., DPhil, who will continue to serve as a member of the Board in the role of Immediate Past Chair.
On Sunday, September 28, Beyond the Pale Brewing Company in Ottawa proudly hosted its annual charity bike ride, bringing together more than 80 passionate participants in support of brain research. This year’s event carried profound personal meaning.
Dr. Sylvia Villeneuve is accelerating research on Alzheimer’s across the globe. By sharing comprehensive data from preclinical Alzheimer’s disease (AD) patients, the Canadian Alzheimer’s Prevention Data Repository and Sharing (CAP) platform, headed by Villeneuve, is bolstering research studies across hundreds of research groups. Already, the platform is hosting data that has been used to uncover significant findings, enabling a greater understanding of the disease in its early stages – before symptoms appear.
